BioCentury
ARTICLE | Company News

Novartis, Torrent autoimmune news

October 26, 2015 7:00 AM UTC

The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (PTO) found that U.S. Patent No. 8,324,283 covering Novartis’ Gilenya fingolimod is unpatentable for obviousness. Torr...